ARCHIVES

DCCP Board Approves Concepts For Nearly $20 Million In Grants, Contracts, Including New Inhibitors Study

This article is from The Cancer Letter archive.

Vol. 09 No. 23 | June 10, 1983

Download PDF Visit The Full Archive

Related Articles

Group Chairmen Criticize NCI Budget Priorities

July 11, 2003

Von Eschenbach Candidacy for FDA Hampered By Three Republican Holds.

December 1, 2006

NCI Spent $381.2 Million On PR From 2006 to 2012, Vastly Outspending Other NIH, FDA Units

March 1, 2013

Study Finds No Benefit From CT In Lung Cancer; Advocacy Group Alleges “Delaying Tactic.”

March 9, 2007

“Miracle-Gro for Cancer?” ODAC Members Vent At Amgen And J&J Over Claims, Advertising.

May 18, 2007

Stand Up To Cancer Says $80 Million in Pledges Raised

September 17, 2010